Genome engineering of stem cell organoids for disease modeling

Area of Science:

• Biomedical Engineering
• Stem Cell Biology
• Genomics

Background:

• Precision medicine requires advanced disease models reflecting individual variability.
• Current models struggle to recapitulate molecular, cellular, and organ-level disease processes.
• Stem cell technologies offer a path toward personalized disease modeling.

Purpose of the Study:

• To summarize recent advances in engineering stem cell organoids for human disease modeling.
• To highlight the potential of organoids in precision medicine research.
• To discuss future perspectives in this rapidly developing field.

Main Methods:

• Derivation of patient-specific tissue organoids from pluripotent and adult stem cells.
• Engineering organoids using genome editing tools to mimic disease-specific genetic and epigenetic alterations.
• Utilizing organoids as sophisticated in vitro models for fundamental and biomedical research.

Main Results:

• Development of diverse tissue organoids from patient-derived stem cells.
• Successful engineering of organoids to recapitulate patient-specific disease states.
• Establishment of advanced in vitro systems for studying disease mechanisms.

Conclusions:

• Engineered stem cell organoids represent a significant breakthrough in human disease modeling.
• These models are crucial for advancing personalized medicine and drug discovery.
• Future research will likely focus on refining organoid complexity and applications.